Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4 (disorder)
|
phenotype |
|
Finding
|
1
|
1
|
0.300 |
None |
|
0 |
1
|
|
|
hearing impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
740
|
337
|
0.210 |
None |
1.000 |
2 |
1
|
2010 |
2012 |
Hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
613
|
283
|
0.210 |
None |
1.000 |
2 |
|
2010 |
2010 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.200 |
None |
1.000 |
2 |
|
2009 |
2011 |
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
|
phenotype |
|
Finding
|
63
|
|
0.200 |
None |
1.000 |
2 |
|
2008 |
2011 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
63
|
|
0.200 |
None |
1.000 |
2 |
|
2008 |
2011 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
63
|
2
|
0.200 |
None |
1.000 |
2 |
|
2008 |
2011 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.200 |
None |
1.000 |
2 |
|
2009 |
2011 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Right Ventricular Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
160
|
6
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Myocardial Reperfusion Injury
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
226
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Fatty Liver, Alcoholic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
94
|
6
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Jaundice, Obstructive
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
66
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Polycystic Kidney, Type 1 Autosomal Dominant Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Congenital Abnormality
|
10
|
2
|
0.200 |
None |
1.000 |
1 |
|
2018 |
2018 |
Liver Failure, Acute
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
282
|
21
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Toxic effect of carbon tetrachloride
|
disease |
Chemically-Induced Disorders
|
Injury or Poisoning
|
6
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Congenital Hyperinsulinism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
62
|
27
|
0.130 |
None |
1.000 |
3 |
|
2008 |
2017 |
Hyperinsulinemic hypoglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
52
|
6
|
0.110 |
None |
1.000 |
1 |
|
2008 |
2008 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.110 |
None |
1.000 |
1 |
|
2003 |
2003 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.100 |
None |
0.971 |
34 |
2
|
1997 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.100 |
None |
0.969 |
32 |
2
|
1997 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
16 |
|
2008 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
14 |
|
2008 |
2020 |